Brandon Wustman

SVP of R&D at ReCode Therapeutics - Menlo Park, CA, US

Brandon Wustman's Contact Details
HQ
408-585-1700
Location
San Diego,California,United States
Company
ReCode Therapeutics
Brandon Wustman's Company Details
ReCode Therapeutics logo, ReCode Therapeutics contact details

ReCode Therapeutics

Menlo Park, CA, US • 50 - 99 Employees
BioTech/Drugs

ReCode Therapeutics is an integrated genetic medicines company developing targeted, disease-modifying therapies for patients with life-limiting respiratory diseases. The Company's diverse pipeline includes lead programs for cystic fibrosis (CF) caused by nonsense mutations, and primary ciliary dyskinesia (PCD). ReCode has developed a non-viral delivery therapeutic platform that enables it to precisely deliver its medicines safely and effectively. The Company is leveraging its lipid nanoparticle and nucleic acid technologies across multiple modalities, including mRNA-mediated replacement therapies, first-in-class tRNA NanoCorrectors for diseases caused by nonsense mutations, and gene editing. For more information, visit www.recodetx.com or contact us at info@recodetx.com.

N/A
Details about ReCode Therapeutics
Frequently Asked Questions about Brandon Wustman
Brandon Wustman currently works for ReCode Therapeutics.
Brandon Wustman's role at ReCode Therapeutics is SVP of R&D.
Brandon Wustman's email address is ***@recodetx.com. To view Brandon Wustman's full email address, please signup to ConnectPlex.
Brandon Wustman works in the Research industry.
Brandon Wustman's colleagues at ReCode Therapeutics are Cameron Ross, Cliff Tiong, Ishita Agarwal, Min Chen, Sam Iniguez, Xueliang Yu, Hu Meng and others.
Brandon Wustman's phone number is 408-585-1700
See more information about Brandon Wustman